Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-3
|
Results: 3
Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients
Authors:
McNeeley, PA Iverson, GM Furie, RA Cash, JM Cronin, ME Katz, RS Weisman, MH Aranow, C Linnik, MD
Citation:
Pa. Mcneeley et al., Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients, LUPUS, 10(8), 2001, pp. 526-532
Treatment of systemic lupus erythematosus with LJP 394
Authors:
Furie, RA Cash, JM Cronin, ME Katz, RS Weisman, MH Aranow, C Liebling, MR Hudson, NP Berner, CM Coutts, S de Haan, HA
Citation:
Ra. Furie et al., Treatment of systemic lupus erythematosus with LJP 394, J RHEUMATOL, 28(2), 2001, pp. 257-265
Epidemiology of cardiovascular disease in systemic lupus erythematosus
Authors:
Aranow, C Ginzler, EM
Citation:
C. Aranow et Em. Ginzler, Epidemiology of cardiovascular disease in systemic lupus erythematosus, LUPUS, 9(3), 2000, pp. 166-169
Risultati:
1-3
|